课题基金 / 基金详情

Pharmacological Response of Smooth Muscle is related With its Myosin Phosphorylation.

Pharmacological Response of Smooth Muscle is related With its Myosin Phosphorylation.
平滑肌的药理反应与其肌球蛋白磷酸化有关。
批准号:
63480475
负责人:
KOHAMA Kazuhiro
金额:
$4.1万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989

项目摘要

项目成果

KOHAMA Kazuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
NA0344是一种新型的抗生素衍生物,它能抑制含有磷酸酶和钙调蛋白/肌球蛋白轻链(MLCK)活性的20,000 mR肌球蛋白轻链(LC)的磷酸化(IC_(50)=6.2×10~(-6)g/ml)。NA0344还抑制肌球蛋白与肌球蛋白的相互作用,超沉淀法和ATPase活性检测结果分别为3.7x10;-7>和3.8×10;-7>g/ml。NA0344部分抑制肌球蛋白磷酸化的肌球蛋白包括未磷酸化的肌球蛋白、具有未磷酸化LC和磷酸化LC的异二聚体肌球蛋白以及具有LC磷酸化的同源二聚体肌球蛋白。我们建立了分离这些异构体的分析电泳法,发现天然肌球蛋白中的同源二聚体的IC_(50)为10~(-7)g/ml。如果我们假设只有同源二聚体在肌动蛋白-肌球蛋白-ATP相互作用中是活跃的,那么这种相互作用的抑制可以通过肌球蛋白与MLCK的磷酸化来解释。最近,冈田酸被报道增强了肌动蛋白-肌球蛋白-ATP的相互作用。这种作用被解释为通过抑制磷酸酶活性而促进磷酸化而起作用。我们成功地制备了不含磷酸酶活性的天然肌球蛋白。使用该制剂,观察到了增强作用,表明冈田酸直接通过肌球蛋白增强了相互作用。
英文摘要
NA0344, a novel derivative of antibiotics, inhibited phosphorylation of 20,000 Mr myosin light chain (LC) of smooth muscle native actomyosin containing both phosphotase and calmodulin/myosin LC kinas (MLCK) activity (IC_<50> = 6.2 x 10^<-6> g/ml). The inhibitory effect is attributable to the direct inhibition of MLCK.NA0344 also inhibited actin-myosin-ATP interaction of the native actomyosin with IC_<50> = 3.7 x 10^<-7> and 3.8 x 10^<-7> g/ml as monitored by superprecipitation and ATPase activity, respectively.Thoretically, myosin whose phosphorylation is partially inhibited by NA0344 comprises from unphosphorylated myosin, heterodimer myosin isoform with an unphosphorylated LC and a phosphorylated LC, and homodimer myosin isoform with both LC phosphorylated. We have developed the analytical electrophoresis separating these isomers and found that IC_<50> for the homodimer in native actomyosin was at the level of 10^<-7> g/ml. If we assume that only the homodimer is active in actin-myosin-ATP interaction, inhibition of the interaction can be explatined by that of myosin phosphorylation with MLCK.Recently, okadaic acid has been reported to enhance actin-myosin-ATP interaction. The effect is interpreted to be mediated by inhibiting phosphatase activity resulting in the enhancement of phosphorylation. We succeeded in preparing the native actomyosin which does not contain phosphatase activity. With this preparation, the enhancing effect was observed, indicating that okadaic acid enhances the interaction directly through myosins.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Kohama,K.,TakanoーOhmura,H.,Sohda,M.,Hiranuma,T.and Hachisu,M.: "Progress in Clinical and Biological Research,Vol.315_:“MUSCLE ENERGETICS"(Paul,R.J.,Elzinga,G.and Yamada,K.,eds.)" Alan R.Liss,Inc.,New York, 100-103 (1989)
Kohama, K.、Takano-Ohmura, H.、Sohda, M.、Hiranuma, T. 和 Hachisu, M.:“临床和生物学研究进展,第 315 卷_:“肌肉能量”(Paul,R.J.,Elzinga,艾伦·R·利斯公司,纽约,100-103 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kahama,K.,Takano-Ohmuro,H.,Sohda,M.,Ozaki,H.,Karaki,H.,Hiranuma,T.and Hachisu,M.: "Effects of NA0344,a new antihypertensive,on the actin-myosin-ATP interaction and myosin light chain phosphorylation in smooth muscle:dissociation of the effects"
Kahama,K.、Takano-Ohmuro,H.、Sohda,M.、Ozaki,H.、Karaki,H.、Hiranuma,T. 和 Hachisu,M.:“NA0344(一种新型抗高血压药)对肌动蛋白的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小浜一弘: 蛋白質・核酸・酸素. 33. 2051-2066 (1988)
奥巴马和弘:蛋白质、核酸、氧气。33。2051-2066 (1988)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kohama,K.,TakanoーOhmuro,H.,Sohda,M.,Ozaki,H.,Karaki,H.,Hiranuma,T.and Hachisu,M.: "Effects of NA0344,a new antihypertensive,on the actinーmyosinーATP interaction and myosin liqht chain phosphorylation in vitro" Gen.Pharmac.22. 465-474 (1991)
Kohama, K.、Takano-Ohmuro, H.、Sohda, M.、Ozaki, H.、Karaki, H.、Hiranuma, T. 和 Hachisu, M.:“NA0344(一种新型抗高血压药)对肌动蛋白的影响体外肌球蛋白-ATP 相互作用和肌球蛋白轻链磷酸化”Gen.Pharmac.22. 465-474 (1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    A novel regulatory way of smooth muscle contraction
    • 批准号:
      16209007
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.2万
    • 财政年份:
      2004
    • 负责人:
      KOHAMA Kazuhiro
    • 依托单位:
    Smooth muscle regulation
    • 批准号:
      13307005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.12万
    • 财政年份:
      2001
    • 负责人:
      KOHAMA Kazuhiro
    • 依托单位:
    Structure and function of Ca-sensitive myosins
    • 批准号:
      10044236
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.26万
    • 财政年份:
      1998
    • 负责人:
      KOHAMA Kazuhiro
    • 依托单位:
    Refulatory activity of myosin light chain kinase in smooth muscle cell
    • 批准号:
      10470022
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.7万
    • 财政年份:
      1998
    • 负责人:
      KOHAMA Kazuhiro
    • 依托单位:
    国内基金
    海外基金
    探索肌球蛋白(myosin)成员在马铃薯纺锤形块茎类病毒(PSTVd)细胞内运动中的作用
    • 批准号:
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2024
    • 负责人:
      吴健
    • 依托单位:
    抗磷脂综合征新型致病性抗体-抗Myosin5A抗体临床价值的多中心验证研究
    肌球蛋白Myosin VI调节自噬影响ER阳性乳腺癌进展和他莫昔芬治疗敏感性的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      周珏宇
    • 依托单位:
    Myosin19乳酰化致线粒体内嵴结构重排在脓毒症心脏功能障碍中的作用机制